Europe, the Middle East and Africa Cell Counting Market Outlook, Trend, Growth and Share Estimation Analysis and Forecast 2020-2030
Market
Analysis
The global Europe,
the Middle East and Africa Cell Counting Market was valued USD 8.47 billion in 2018 and likely to grow at a
5.8% CAGR between 2019- 2025, reveals the new Market Research Future (MRFR)
report. Cell counts are vital to monitor cell health and proliferation rate and
assess immortalization or transformation. It is also important for seeding
cells for subsequent experiments, infection or transfection, and preparing
cell-based assays. Cell counting is widely used in research institutes,
hospitals, pharmaceutical and biotechnology companies, and others.
Various factors are
adding to the global Europe, the Middle East and Africa Cell Counting Market
share. These factors, as per the new MRFR report, include increasing use of
automated haematology analysers and high-throughput flow cytometry, development
of improved image analysis and enhanced solutions, rising prevalence of blood
disorders and target diseases, and increasing research and development
expenditure. Additional factors adding market growth include new product
launches and increasing use of cell counting instruments in neuroscience,
immunology, and cancer biology.
On the contrary,
product recalls, and the soaring price of advanced
cell counting systems are factors that may limit the Europe, the Middle
East and Africa Cell Counting Market growth over the forecast period.
Market
Segmentation
The Market Research
Future Report provides an inclusive segmental analysis of the global Europe,
the Middle East and Africa Cell Counting Market based on end user, application,
and product.
·
By product, the global cell counting market is segmented into instruments
and consumables. Of these, the consumables segment will lead the market over
the forecast period for its repeated purchase over instrument products.
·
By applications, the global cell counting market is segmented into clinical and
diagnostic applications, research applications, and others. Of these, the
research application segment will dominate the market over the forecast period
for the increased funding for stem cell research.
·
By end user
segments, the global cell counting market is segmented into
research institutes, hospitals, pharmaceutical, and biotechnology companies,
and others. Of these, pharmaceutical and biotechnology companies will have a
major share in the market over the forecast period as they are largely used in
the R&D of new drugs & therapies.
Regional
Analysis
Based on region, the
global cell counting market report covers the recent trends and growth
opportunities across Europe, the Americas, the Asia Pacific (APAC), and the
Middle East and Africa (MEA). Of these, the Americas will dominate the market
over the forecast period. Factors propelling the cell counting market growth in
the region include huge support from the government in the likes of grants and
funds, availability of products that are technologically advanced, presence of
well-established pharmaceutical & biotechnology industry, and rising
prevalence of cancer.
The cell counting
market in Europe is predicted to hold the second-largest share over the
forecast period. Factors propelling the cell counting market growth in the
region include growing healthcare expenditure, the presence of top
manufacturers, support and funding for the healthcare industry by government
bodies, and increasing research and development.
The cell counting
market in the APAC region will grow at the fastest pace over the forecast
period for the increasing drug development researches and developing healthcare
infrastructure.
The cell counting
market in the MEA is predicted to have the smallest share over the forecast
period for limited development of healthcare facilities and low per capita
disposable incomes.
Key
Players
Key players profiled
in the global Europe, the Middle East and Africa Cell Counting Market report
include Abbott Laboratories (US), Sysmex Corporation (Japan), PerkinElmer,
Inc. (US), Agilent Technologies, Inc. (US), Olympus Corporation (Japan), Logos
Biosystems, Inc. (South Korea), Bio-Rad Laboratories, Inc. (US), Danaher
Corporation (US), Merck KGaA (Germany), and Thermo Fisher Scientific (US).
Industry players have incorporated several strategies to create a footprint in
the market such as extensive research and development activities, strategic
alliances, contracts, mergers and acquisitions, and joint ventures.
Related Report-
Process
Analytical Technology (PAT) Market Research Report- Global Forecast To 2027
Global
Anti Asthma Drugs Market – Forecast to 2027
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment